220 related articles for article (PubMed ID: 25936632)
1. Dramatic reduction of clindamycin serum concentration in staphylococcal osteoarticular infection patients treated with the oral clindamycin-rifampicin combination.
Bernard A; Kermarrec G; Parize P; Caruba T; Bouvet A; Mainardi JL; Sabatier B; Nich C
J Infect; 2015 Aug; 71(2):200-6. PubMed ID: 25936632
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of a combined oral clindamycin?rifampicin regimen for therapy of staphylococcal osteoarticular infections.
Czekaj J; Dinh A; Moldovan A; Vaudaux P; Gras G; Hoffmeyer P; Lew D; Bernard L; Uçkay I
Scand J Infect Dis; 2011 Dec; 43(11-12):962-7. PubMed ID: 21916775
[TBL] [Abstract][Full Text] [Related]
3. Clindamycin and rifampicin: No bull's eye without a target.
Béraud G; Le Moal G; Sury S; Venisse N
J Infect; 2016 Jan; 72(1):120-1. PubMed ID: 26416473
[No Abstract] [Full Text] [Related]
4. Decreased serum linezolid concentrations in two patients receiving linezolid and rifampicin due to bone infections.
Hoyo I; Martínez-Pastor J; Garcia-Ramiro S; Climent C; Brunet M; Cuesta M; Mensa J; Soriano A
Scand J Infect Dis; 2012 Jul; 44(7):548-50. PubMed ID: 22385321
[TBL] [Abstract][Full Text] [Related]
5. High-dose trimethoprim-sulfamethoxazole and clindamycin for Staphylococcus aureus endocarditis.
Tissot-Dupont H; Gouriet F; Oliver L; Jamme M; Casalta JP; Jimeno MT; Arregle F; Lavoute C; Hubert S; Philip M; Martel H; Riberi A; Habib G; Raoult D
Int J Antimicrob Agents; 2019 Aug; 54(2):143-148. PubMed ID: 31181351
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetic variability of clindamycin and influence of rifampicin on clindamycin concentration in patients with bone and joint infections.
Curis E; Pestre V; Jullien V; Eyrolle L; Archambeau D; Morand P; Gatin L; Karoubi M; Pinar N; Dumaine V; Nguyen Van JC; Babinet A; Anract P; Salmon D
Infection; 2015 Aug; 43(4):473-81. PubMed ID: 25837442
[TBL] [Abstract][Full Text] [Related]
7. Influence of the clindamycin administration route on the magnitude of clindamycin-rifampicin interaction: a prospective pharmacokinetic study.
Zeller V; Magreault S; Heym B; Salmon D; Kitzis MD; Billaud E; Marmor S; Jannot AS; Salomon L; Jullien V
Clin Microbiol Infect; 2021 Dec; 27(12):1857.e1-1857.e7. PubMed ID: 33915288
[TBL] [Abstract][Full Text] [Related]
8. [Cotrimoxazole plus rifampicin in the treatment of staphylococcal osteoarticular infection].
Sánchez C; Matamala A; Salavert M; Cuchí E; Pons M; Anglés F; Garau J
Enferm Infecc Microbiol Clin; 1997 Jan; 15(1):10-3. PubMed ID: 9147500
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetic and dynamic study of levofloxacin and rifampicin in bone and joint infections.
Guillaume M; Garraffo R; Bensalem M; Janssen C; Bland S; Gaillat J; Bru JP
Med Mal Infect; 2012 Sep; 42(9):414-20. PubMed ID: 22944286
[TBL] [Abstract][Full Text] [Related]
10. [Treatment of osteoarticular infections with clindamycin in adults].
El Samad Y; Havet E; Bentayeb H; Olory B; Canarelli B; Lardanchet JF; Douadi Y; Rousseau F; Lescure FX; Mertl P; Eb F; Schmit JL
Med Mal Infect; 2008 Sep; 38(9):465-70. PubMed ID: 18718729
[TBL] [Abstract][Full Text] [Related]
11. Intensified regimen containing rifampicin and moxifloxacin for tuberculous meningitis: an open-label, randomised controlled phase 2 trial.
Ruslami R; Ganiem AR; Dian S; Apriani L; Achmad TH; van der Ven AJ; Borm G; Aarnoutse RE; van Crevel R
Lancet Infect Dis; 2013 Jan; 13(1):27-35. PubMed ID: 23103177
[TBL] [Abstract][Full Text] [Related]
12. Short- versus long-duration levofloxacin plus rifampicin for acute staphylococcal prosthetic joint infection managed with implant retention: a randomised clinical trial.
Lora-Tamayo J; Euba G; Cobo J; Horcajada JP; Soriano A; Sandoval E; Pigrau C; Benito N; Falgueras L; Palomino J; Del Toro MD; Jover-Sáenz A; Iribarren JA; Sánchez-Somolinos M; Ramos A; Fernández-Sampedro M; Riera M; Baraia-Etxaburu JM; Ariza J;
Int J Antimicrob Agents; 2016 Sep; 48(3):310-6. PubMed ID: 27524103
[TBL] [Abstract][Full Text] [Related]
13. Comparative study of the mutant prevention concentrations of vancomycin alone and in combination with levofloxacin, rifampicin and fosfomycin against methicillin-resistant Staphylococcus epidermidis.
Liu LG; Zhu YL; Hu LF; Cheng J; Ye Y; Li JB
J Antibiot (Tokyo); 2013 Dec; 66(12):709-12. PubMed ID: 23981959
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetic interaction between rifampicin and clindamycin in staphylococcal osteoarticular infections.
Goulenok T; Seurat J; Selle A; Jullien V; Leflon-Guibout V; Grall N; Lescure FX; Lepeule R; Bertrand J; Fantin B; Burdet C; Lefort A
Int J Antimicrob Agents; 2023 Aug; 62(2):106885. PubMed ID: 37302771
[TBL] [Abstract][Full Text] [Related]
15. A randomized clinical trial to compare fleroxacin-rifampicin with flucloxacillin or vancomycin for the treatment of staphylococcal infection.
Schrenzel J; Harbarth S; Schockmel G; Genné D; Bregenzer T; Flueckiger U; Petignat C; Jacobs F; Francioli P; Zimmerli W; Lew DP;
Clin Infect Dis; 2004 Nov; 39(9):1285-92. PubMed ID: 15494904
[TBL] [Abstract][Full Text] [Related]
16. Population pharmacokinetics of rifampicin in adult patients with osteoarticular infections: interaction with fusidic acid.
Marsot A; Ménard A; Dupouey J; Muziotti C; Guilhaumou R; Blin O
Br J Clin Pharmacol; 2017 May; 83(5):1039-1047. PubMed ID: 27813241
[TBL] [Abstract][Full Text] [Related]
17. Levofloxacin plus rifampicin conservative treatment of 25 early staphylococcal infections of osteosynthetic devices for rigid internal fixation.
Barberán J; Aguilar L; Giménez MJ; Carroquino G; Granizo JJ; Prieto J
Int J Antimicrob Agents; 2008 Aug; 32(2):154-7. PubMed ID: 18571387
[TBL] [Abstract][Full Text] [Related]
18. Clindamycin vs. first-generation cephalosporins for acute osteoarticular infections of childhood--a prospective quasi-randomized controlled trial.
Peltola H; Pääkkönen M; Kallio P; Kallio MJ;
Clin Microbiol Infect; 2012 Jun; 18(6):582-9. PubMed ID: 22011265
[TBL] [Abstract][Full Text] [Related]
19. Importance of selection and duration of antibiotic regimen in prosthetic joint infections treated with debridement and implant retention.
Tornero E; Morata L; Martínez-Pastor JC; Angulo S; Combalia A; Bori G; García-Ramiro S; Bosch J; Mensa J; Soriano A
J Antimicrob Chemother; 2016 May; 71(5):1395-401. PubMed ID: 26929270
[TBL] [Abstract][Full Text] [Related]
20. Oral clindamycin and rifampicin combination therapy for hidradenitis suppurativa: a prospective study and 1-year follow-up.
Dessinioti C; Zisimou C; Tzanetakou V; Stratigos A; Antoniou C
Clin Exp Dermatol; 2016 Dec; 41(8):852-857. PubMed ID: 27753139
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
